What’s the STORY?

The Oxford Vaccine Group is researching a new way of surveying how well protected we are from vaccine preventable diseases by collecting blood samples from people who represent different groups across society.


The Oxford Vaccine Group is recruiting infants aged 4 – 7 months to a type 1 diabetes prevention trial. POInT (Primary Oral Insulin Trial) is recruiting infants who were screened for diabetes at birth through the INGR1D Study and have been found to be at high risk for developing diabetes.